Howard Berman

Insider Reports History

Entity
Individual
Location
C/O Coya Therapeutics, Inc., 5850 San Felipe St., Suite 500, Houston, TX
Signature
/s/ David Snyder, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Berman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Coya Therapeutics, Inc. Director Stock Option (right to buy) 151K Jan 9, 2025 Direct

Insider Reports Filed by Howard Berman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COYA Coya Therapeutics, Inc. Jan 9, 2025 1 $0 4 Jan 13, 2025 Director
COYA Coya Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Chief Executive Officer, Director
COYA Coya Therapeutics, Inc. Jan 31, 2024 1 $0 4 Feb 2, 2024 Chief Executive Officer, Director
COYA Coya Therapeutics, Inc. Feb 27, 2023 1 $0 4 Mar 1, 2023 Chief Executive Officer, Director
COYA Coya Therapeutics, Inc. Jan 3, 2023 0 $0 4/A Jan 17, 2023 Chief Executive Officer, Director, 10%+ Owner
COYA Coya Therapeutics, Inc. Dec 28, 2022 0 $0 3 Dec 28, 2022 Chief Executive Officer, Director, 10%+ Owner